Gynuity Health Projects

Resources

Resources by Type

Staff Publication (View all)

Mifepristone medical abortion in Albania

Regimens of misoprostol with mifepristone for early medical abortion

Early pregnancy termination

Clostridium sordellii infection in medical abortion

Misoprostol for uterine evacuation in induced abortion and pregnancy failure

Use of sequential serum hCG and sonography for medical abortion only when indicated

Are two doses of misoprostol after mifepristone for early abortion better than one?

Alternatives to mifepristone for early medical abortion

Mifepristone for late first trimester abortion

Can mifepristone medical abortion be simplified?

Methotrexate compared to misoprostol alone for early medical abortion

Assessment of pregnancy duration among termination of pregnancy clients in South Africa

Abortion is for women

The supreme court and the partial-birth abortion ban act of 2003

Reproductive intentions among HIV-positive women and men

Misoprostol for incomplete abortion in Mozambique

Perspectives on reproductive decision-making amongst HIV-infected individuals

Misoprostol for incomplete abortion in Tanzania

Misoprostol for incomplete abortion in Burkina Faso

Treatment of postpartum hemorrhage with misoprostol

Prevention of postpartum hemorrhage with misoprostol

Treatment of incomplete abortion and miscarriage with misoprostol

Misoprostol to treat missed abortion in the first trimester

Supervision for use of mifepristone medical abortion

Community-based kangaroo mother care to prevent neonatal and infant mortality

Integrating medical abortion into safe abortion services in South Africa

Comment on Misoprostol impairs female reproductive tract innate immunity against C. sordellii

Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan

Two distinct oral routes of misoprostol in mifepristone medical abortion

Abortion and sex determination

Sublingual misoprostol after mifepristone

Non-physician clinicians can safely provide first trimester medical abortion

Sublingual misoprostol for incomplete abortion

Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone

Increasing women’s choices in medical abortion in Turkey

Knowledge, attitudes, and practice of abortion among women and doctors in Armenia

Modern Methods of Abortion

Acceptability and feasibility of medical abortion in Nepal

Comparison of serum markers for thrombophilia and autoimmune disease

Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1/2

Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2/2

Alternatives to Routine Follow-Up for Early Medical Abortion

Home administration of misoprostol for early medical abortion in India

High fever following postpartum administration of sublingual misoprostol

What measured blood loss tells us about postpartum bleeding

Misoprostol as adjunct treatment for treatment of postpartum haemorrhage

Unsafe Abortion and Strategies to Reduce its Impact on Women’s Lives